With the Fed likely to be lowering rates until next summer, now is the time to load up on five of our favorite blue-chip ...

The first study of oral sedation for cataract surgery in an office setting found it to be as safe as intravenous anesthesia without the extra time or cost.

But behind the spas’ allure, the evaluation found that clinics nationwide varied widely in their offerings and claims; only 2 ...

BRIUMVI is currently approved in the United States, as well as several countries outside of the U.S., as a one-hour intravenous (IV) infusion administered twice a year, following the starting dose, in ...

Subcutaneous therapy could be the future of non–small cell lung cancer (NSCLC) as it would decrease time needed for treatment ...

Takeda (TSE:4502/NYSE:TAK) today announced that the recently FDA-approved HyHub and HyHub Duo devices are now available in the U.S. for patients 17 years of age and older, as prescribed, who are ...

TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has completed in the randomized cohort of the Phase 3 ENHANCE trial evaluating a consolidated ...

Keeping up with watering your garden can be challenging, but installing a drip irrigation system can ensure your plants never go thirsty. Drip irrigation is a system of hoses, nozzles, sprinklers, and ...

Deep, stable and durable reductions in kallikrein observed Among 32 patients who received a 50 mg dose of lonvo-z as of data cutoff:31 (97%) were ...

PepGen shifts focus to PGN-EDODM1 for Myotonic Dystrophy Type 1 after discontinuing PGN-EDO51 for Duchenne Muscular Dystrophy ...

Scott Galovan noted a "decline of over 20%" in hyaluronic acid injections and intravenous infusion product lines in fiscal Q3 ...

NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) (the Company or TG Therapeutics) today announced its financial results for the third quarter of 2025, along with recent ...